Your browser doesn't support javascript.
loading
ADME SARfari: comparative genomics of drug metabolizing systems.
Davies, Mark; Dedman, Nathan; Hersey, Anne; Papadatos, George; Hall, Matthew D; Cucurull-Sanchez, Lourdes; Jeffrey, Phil; Hasan, Samiul; Eddershaw, Peter J; Overington, John P.
Afiliação
  • Davies M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Dedman N; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Hersey A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Papadatos G; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Hall MD; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Cucurull-Sanchez L; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Jeffrey P; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Hasan S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Eddershaw PJ; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
  • Overington JP; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY and Pfizer Ltd., Granta Park, Great Abington, Cambridge CB21 6GP, UK.
Bioinformatics ; 31(10): 1695-7, 2015 May 15.
Article em En | MEDLINE | ID: mdl-25964657
ABSTRACT
MOTIVATION ADME SARfari is a freely available web resource that enables comparative analyses of drug-disposition genes. It does so by integrating a number of publicly available data sources, which have subsequently been used to build data mining services, predictive tools and visualizations for drug metabolism researchers. The data include the interactions of small molecules with ADME (absorption, distribution, metabolism and excretion) proteins responsible for the metabolism and transport of molecules; available pharmacokinetic (PK) data; protein sequences of ADME-related molecular targets for pre-clinical model species and human; alignments of the orthologues including information on known SNPs (Single Nucleotide Polymorphism) and information on the tissue distribution of these proteins. In addition, in silico models have been developed, which enable users to predict which ADME relevant protein targets a novel compound is likely to interact with.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Software / Farmacocinética Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Software / Farmacocinética Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido